token,frequency
table,58
file,1
number,5
name,5
registrant,1
charter,1
other jurisdiction,1
incorporation,30
organization,5
principal executive,1
telephone,2
area,1
code,1
each class,1
stock,60
trading,3
exchange,4
check,7
mark,7
the registrant,10
a wellknown seasoned issuer,1
o,2
pursuant,18
section,13
period,22
such filing,1
this chapter,1
filer,6
a nonaccelerated filer,1
reporting,16
company,13
growth,34
Ã¾,1
the extended transition,1
financial accounting,1
a shell,1
the aggregate,2
market,48
value,42
the closing,2
price,34
such stock,1
the number,11
common stock,78
the following document,1
reference,76
this report,13
annual meeting,3
executive,4
refer,2
corporation,3
global pharmaceutical sourcing,3
distribution,51
patient access,3
patient care,2
the effectiveness,15
efficiency,5
the pharmaceutical supply,11
chain,13
animal health,10
a comprehensive offering,4
brandname,10
specialty,12
home,4
healthcare,31
equipment,22
a wide variety,4
acute care,4
health,17
order,18
care,16
site,4
dialysis,5
an assortment,1
research,9
reimbursement,21
pharmaceutical consulting,1
niche,1
premium,11
inventory,14
management,40
pharmacy,14
automation,2
packaging,7
an independent thirdparty,1
provider,12
information,38
healthcare industry,1
a compound,1
annual growth,1
rate,56
the growth,4
part,26
pharmaceutical manufacturer,2
addition,31
the pharmaceutical industry,4
other industry,3
age,1
segment,28
the population,4
this age,1
group,26
the rest,1
a substantial portion,2
total healthcare,1
development,7
the advent,1
new research,1
production,29
delivery,7
biotechnology,7
gene,1
therapy,2
continued growth,1
the industry,2
other specialty,5
the continued growth,2
business,111
emphasis,2
other thirdparty,1
utilization,3
the increase,16
generic usage,1
a favorable trend,1
gross profit,20
margin,10
opportunity,1
revenue,64
the prescription,1
volume,2
response,7
cost,23
containment,1
the use,5
efficient drug,1
national attention,1
the overall increase,1
aggregate healthcare,1
drug,22
a beneficial impact,1
prolonged hospital,1
overall healthcare,1
introduction,1
costeffective drug,1
the federal government,7
major health,1
reform,8
legislation,10
access,9
insurance,6
a portion,7
prescription,13
the health,2
law,15
disclosure,15
the healthcare,7
industry,14
enforcement authority,1
fraud,13
abuse,7
medical device,1
page,6
certain risk,2
diverse network,1
service,22
pharmaceutical distribution,11
the primary supplier,1
a broad range,4
the efficiency,2
effectiveness,5
the delivery,4
strategy,6
the global pharmaceutical supply,1
channel,9
valueadded distribution,1
global commercialization,7
a seamless,1
unified way,1
operating,50
income,103
the execution,1
size,2
breadth,1
capital,27
position,17
superior distribution,1
competitiveness,1
a leader,1
community,2
other blood,4
the new biotechnology,1
the near future,1
the generic marketplace,1
generic product,2
private label,2
program,19
source,4
a valueadded generic formulary program,1
compliance,31
manufacturer,8
international presence,1
global manufacturer,1
commercialization,5
patient,3
assistance,2
rapid new product,1
marketing,4
product,18
logistical support,1
independent community,4
pharmaceutical benefit,1
merchandising,1
network,3
retail pharmacy,1
the country,1
purchasing,9
hospital,2
retail healthcare,6
robust distribution,1
facility,53
a national distribution,1
center,4
a single shipping,1
destination,1
productivity,2
warehouse,2
technology,14
adopt,1
leverage,2
fullservice,1
contract,10
field,1
patient assistance,1
mitigation,1
other market,1
global specialty,5
transportation,6
the biopharmaceutical industry,5
platform,2
the introduction,4
feed,4
the companion,4
animal,8
a variety,12
e,2
commerce,1
fulfillment inventory,1
system,8
procurement,1
consultation,1
special order,1
fulfillment,1
core,3
strategic focus,1
certain noncore,1
time,57
structure,5
reportable segment,29
separate reportable segment,3
the purpose,8
presentation,6
strategic global sourcing,1
acute,3
a number,16
plasma,3
disease,3
staffing,3
additional consulting,3
software,8
institutional healthcare,3
a full suite,3
integrated manufacturer,3
clinical trial,4
support,12
postapproval,4
force,4
the majority,4
geographic focus,1
either healthcare,1
type,1
customer,22
effective manner,2
national account,1
close coordination,1
local distribution,1
respective product,1
an enterprisewide marketing,1
all other marketing,1
the company,82
a diverse customer,1
base,1
mail,3
other alternate,2
physician group,1
regional retail drugstore,2
mass,2
the primary source,2
supply,4
overthecounter product,1
beauty,1
aid,1
the operating,11
the fiscal year,122
the loss,22
any major customer,1
relationship,7
future revenue,1
accordance,27
expiration,5
cash,95
none,3
a supplier,1
a majority,8
fiscal year,15
fullservice wholesale pharmaceutical distribution,1
primary enterprise,1
resource,1
planning,1
a single primary,1
electronic order,1
entry,1
invoice preparation,1
the ability,9
entitywide infrastructure,1
environment,1
speed,1
advanced information,1
example,9
an effort,1
future pedigree,1
other supply,1
custody,2
pharmaceutical compounding,10
profitability,6
secure,1
a platform,1
demand,6
replenishment,1
singlesource,1
billing,2
thirdparty,7
realtime price,1
incentive,2
purchase,8
electronic interface,1
transactional volume,1
the warehouse,1
significant portion,1
competitive global environment,1
the distribution,16
own warehousing,1
competition,4
credit,70
the principal,3
the course,1
the subject,3
registration,1
other intellectual property,1
the conduct,1
such intellectual property,1
a combination,4
trade,20
secret patent,1
copyright,1
confidentiality,1
relate,2
automated pharmacy,1
medication,1
certain warehousing,1
proprietary packaging,1
patent protection,1
proprietary intellectual property,1
the intellectual property,1
infringement,1
collective bargaining,2
other such bargaining,1
connection,36
the negotiation,1
new collective bargaining,1
the expiration,4
adequate contingency,1
place,4
the event,1
state,52
extensive oversight,1
storage,2
andor distribution,1
various security,3
comply,2
the sale,11
outsourcing,2
current good manufacturing,3
cgmps,3
broad enforcement,3
an agreement,9
a consent,4
audit,18
an independent cgmp,7
expert,22
conformity,4
the independent cgmp,11
the resumption,5
the ongoing compliance,1
subsidiary,8
commercial distribution,3
the federal antikickback,1
statute,3
the antikickback,1
receiving,2
any remuneration,2
the purchasing,1
leasing,1
a referral,1
lease,7
arrange,1
any way,3
other federal healthcare,1
the submission,1
payment,12
the government,2
the case,5
the fraud,1
scope,1
varied interpretation,1
the safety,2
counterfeit,2
the federal level,2
the supply,6
security,18
federal traceability,2
the lot,1
level,4
pedigree,2
all supplychain,2
an electronic interoperable prescription,2
traceability,2
licensing,6
comparable state,1
wholesale distributor,1
third party,1
a new category,1
no assurance,10
additional related state,2
any failure,2
suspension,5
delay,2
the cost,4
the regulation,1
private health,1
benefit,42
scrutiny,2
the state,2
this process,3
additional legislation,1
andor,17
regulation,7
the production,6
pricing,21
other healthcare,1
significant additional compliance,1
the discontinuation,1
ability,21
a material adverse effect,16
financial condition,21
various federal state,3
respect,28
handling,1
disposal,1
laboratory,1
the failure,4
a significant impact,1
a discussion,1
other litigation,2
failure,10
forth privacy,1
the privacy,1
the security,1
protected health,3
maintain,2
andor access,1
location,1
protection,2
the manner,1
violation,1
federal privacy,1
privacy,6
new notification,1
specific security,1
final rule,1
enforcement,3
act,1
the meaning,2
other personal information,1
sensitive personal information,1
such information,1
identifiable information,1
applicable privacy,1
the promulgation,2
a privacy,1
other applicable privacy,1
available information,3
website,5
the website,1
charge,5
investoramerisourcebergencom,1
the following discussion,2
these risk,1
forth,4
the reader,1
this list,1
a complete statement,1
unfavorable brand,1
generic pharmaceutical pricing,2
profit,17
consolidated operating,1
an adverse effect,3
the purchase,9
brand,11
wholesale acquisition,1
the reference,2
regard,9
the value,2
policy,7
wac list,1
inflation,5
deflation,5
certain distribution,1
a price,2
appreciation,1
component,1
a result,23
fluctuation,1
the timing,7
extent,1
the frequency,2
generic pharmaceutical price,2
the implementation,8
voluntary manufacturer,1
the negative impact,1
consolidation,36
detail,1
a material,4
adverse effect,1
the impact,15
power,2
pressure,2
the pharmaceutical distribution,4
diversion,3
the risk,6
various state,2
burden,1
the bottle level,1
a category,1
draft,1
final guidance,1
implementation,2
factor,2
public concern,1
the abuse,5
litigation,42
the misuse,2
federal state,6
local governmental,2
monitor product,1
prescribing,1
dispensing,4
other chain,1
compounding,1
current public concern,1
contracting,5
the methodology,2
discounting,1
occasion,1
certain brand,2
private litigation,1
pharmaceutical pricing,1
healthcare access,1
rebate,5
the scope,1
every aspect,1
the law,1
other healthcare legislation,1
federal drug,1
line,1
single source,1
innovator,1
multiple source,2
oral solid dosage,1
form,18
the future,13
impact,4
any reduction,2
cause,1
an adverse impact,3
related reporting,1
oncology,2
a final rule,2
outpatient hospital,1
discount,7
this policy,1
statutory authority,1
process,5
calendar,2
year,10
outpatient prospective payment,1
rule,1
appropriate payment,1
a reduced rate,1
the addon payment,1
new separatelypayable part,1
data,2
first quarter,1
spending,1
a potential proposal,1
model,5
tie reimbursement,1
international drug,1
the structure,2
this time,1
the context,1
advance,2
notice,4
certain price,1
those price,1
administrative action,2
affordability,1
multipayer,1
importation,1
federal healthcare,1
government,13
other government,1
the referral,1
a patient,2
treatment,2
the ordering,1
give federal enforcement,1
funding,1
judicial authority,1
a manner,1
concern,3
regulatory action,1
governmental,2
a significant number,3
the diversion,3
an intent,1
control,9
further review,1
engage,1
significant due diligence,1
monitoring,2
harm,2
reputation,10
the objective,3
a global resolution,9
the multidistrict,3
opioid litigation,3
other related state,3
court,15
the large number,2
the complexity,4
difficulty,3
the resulting uncertainty,2
a potential global resolution,2
trial,6
the outcome,8
the result,6
injunctive relief,2
the adverse resolution,2
historical level,1
deployment,1
an opioid excise,1
tax,148
effect,9
the initial sale,1
increased licensure,1
an assessment,4
additional state,1
enact legislation,1
such legislation,1
the dispensing,2
the provision,5
antitrust class,1
action,2
commercial employment,1
environmental intellectual property,1
the above,3
risk,12
ordinary business,1
the defense,1
resolution,8
the marketing,3
sale,8
administrative liability,1
possible exclusion,1
participation,3
settlement,13
judgment,5
fine,1
the basis,2
qui,2
tam,3
the qui,1
a private person,1
a relator,2
behalf,5
the filing,1
a qui tam,1
complaint,3
the action,1
seal,2
the applicable court,1
qui tam,1
any health,1
the litigation,2
any portion,1
a fiveyear term,2
renewal,1
a significant customer,6
top ten,1
such customer,2
the customer,8
the extent,9
such early termination,1
the contract,1
each year,3
renew renegotiate,1
any significant customer,1
date,16
strategic arrangement,1
agreement,13
arrangement,10
acquisition,19
expectation,1
the potential,2
innovation,1
the arrangement,1
an ongoing basis,1
the potential inability,1
improved generic drug,1
inability,1
the potential disruption,1
the duration,1
any disruption,1
flow,11
financial flexibility,1
potential,1
supplier,3
the transaction,4
the overall strategic relationship,1
an efficient,1
furtherance,1
the relationship,3
the right,6
the obligation,2
the public market,1
collaboration,1
attention,1
the anticipated time,2
frame,2
a material adverse impact,4
a disruption,1
generic purchasing,1
the primary distributor,1
generic pharmaceutical program,1
any reason,3
natural disaster,1
labor,1
disruption,5
governmental action,1
an obligation,1
termination,1
possible revocation,1
substance,2
a large corporation,1
the repeal,1
lastin,1
firstout,5
opioid,6
effective tax,16
historical tax,1
precedent,1
foreign tax,2
relevant tax,1
any such challenge,1
the interpretation,1
thereof,1
the ambiguity,1
the subjectivity,1
the geographic mix,1
any particular period,1
provision,10
share,42
the period,18
the suspension,6
revocation,2
compound,1
store,1
distribute,1
the refusal,1
a registration,1
any such facility,1
any enforcement action,1
the compounding,2
the illegal diversion,2
a regulatory agency,1
tribunal,1
ii seize,1
recall,3
iii,2
other authority,1
agency,1
correspondence,2
timely manner,1
effort,2
the assertion,2
the commencement,2
civil criminal,1
a period,7
several state,1
temporary licensing,1
the status,6
these state,1
oversight,1
the business,5
a warning,1
letter,4
a series,2
the sufficiency,1
timing,2
this warning,1
a failure,4
regulatory authority,1
warning,1
operation,3
an enforcement action,1
license revocation,1
labeling,3
death,3
reputational harm,2
outpatient,1
ambulatory,1
surgery,1
administration,1
the injury,1
quality,1
manufacturing,1
flaws improper packaging,1
human,1
other error,1
a recall,1
safety,2
the ordinary course,4
retrieval,1
negative publicity,1
publicity,1
a quality,1
issue,1
accurate,1
inaccurate,1
acceptance,1
decrease,7
result,2
liability,20
a class,1
multidistrict litigation,1
such action,1
patient harm,2
a competitor,1
a hospital pharmacy,1
liquidity,7
future insurance,2
coverage,2
insufficient,1
any liability,2
the commercial insurance,1
any particular time,2
assessment discussion,1
negotiation,1
public disclosure,1
experience,2
long term,1
the assumption,1
the fair value,55
the imposition,2
adequate,1
the integration,6
financial review,1
the review,2
consideration,3
face,3
portfolio,1
an asset,2
a business,4
alternative exit,1
the achievement,1
a divestiture,1
antibribery anticorruption,1
international trade,3
financial position,9
export,2
sanction,1
similar anticorruption,1
any violation,1
substantial liability,1
a loss,19
the market,4
favorable treatment,1
an adequate system,1
internal accounting,1
disgorgement,1
debarment,1
foreign government,2
international business,1
an adverse outcome,2
any such investigation,2
recession,1
currency,5
volatility,8
uncertainty,7
foreign policy,1
a particular location,1
money,3
financial market,3
a downgrade,2
the capital,5
significant disruption,1
downward movement,1
material,3
rating,5
outstanding debt,2
certain financial performance,1
an increase,25
debt,33
a decline,1
any announcement,1
review,5
a negative outlook,1
public debt,1
private debt,1
overall borrowing,1
the bankruptcy,4
insolvency,6
other credit,4
a significant supplier,1
rise,1
the solvency,2
creditworthiness,3
any supplier,1
a time,1
the supplier,1
a substantial account,1
payable balance,1
assessment,23
analysis,8
a security,1
interest,60
exposure,7
the position,3
any customer,1
a substantial amount,1
receivable,9
a public filing,1
breach,5
certain financial debt,1
the quarter,5
sufficient,1
substantial doubt,1
indebtedness thereunder,1
the credit,1
the foregoing,4
balance,5
this customer,1
such date,1
sophisticated information,3
process analyze,1
manage,1
numerous distribution,1
ship,1
a timely basis,1
other product,1
the accurate billing,1
a program,4
a thirdparty,1
the information,3
the proliferation,1
cloudbased infrastructure,1
sophistication,1
cyber,4
interruption,1
the disclosure,3
misuse,1
confidential,1
proprietary information,1
enhancement,1
attack,1
damage,2
unauthorized access,1
a priority,1
robust information,1
any information,1
the international transfer,2
the collection,1
processing,1
transfer,3
the transfer,3
certain state,2
federal law,1
collection,1
use,5
goodwill,23
a further significant charge,2
accounting,17
impairment,31
an annual basis,1
potential impairment exist,1
performance,18
relative,1
significant negative industry,1
a significant decline,1
capitalization,2
a sustained period,1
a change,1
divestiture,1
asset,19
the testing,1
the entry,1
a recoverability,5
an impairment loss,4
the amount,28
fair value,26
a rise,1
the accuracy,2
validity,2
any impairment,1
such charge,1
the occurrence,1
financial performance,1
physical damage,1
partial closure,1
longterm disruption,1
nature,1
occur,1
combination,5
climate,1
change,2
energy,2
the availability,5
any longterm disruption,1
depend,1
a decrease,7
the general economy,1
discretionary spending,1
bad debt,3
expense,76
office,5
corporate headquarters,1
a robust distribution,1
satisfactory condition,1
the following,8
a list,2
executive leadership,1
various leadership,1
the trading,2
symbol,2
record,2
board,26
the quarterly dividend,2
quarterly cash,2
the payment,10
amount,8
the discretion,3
agent,3
co,1
internet,1
wwwcomputersharecominvestor,1
the total number,2
the average price,1
the approximate dollar,1
each month,2
a share,6
repurchase program,9
subject,12
a total,8
authorization,5
this program,13
b,5
a new share,3
availability,5
restricted stock,16
this graph,1
cumulative total,1
stockholder,3
the performance,3
an index,1
peer,1
the graph,2
the common stock,5
represent fiscal yearend,1
index,3
the last trading,1
day,1
each fiscal quarter,1
wholesale pharmaceutical distribution,1
reinvestment,1
conjunction,2
thereto,20
net income,16
loss,34
common share,1
expense net net income,1
net,50
equity,22
a b,1
employee,15
severance,30
gain,17
antitrust litigation,22
remediation,17
reversal,2
an equity,6
investment,13
no income,4
expense net,7
a noncustomer note,5
early retirement,6
c,1
d,3
pension,1
impairment charge,3
herein,7
this executive,1
summary,5
the prior fiscal year,51
the revenue,4
strong specialty,3
the specialty,20
joint venture,18
total gross profit,1
the current fiscal year,14
a lastin,1
the current year,4
comparison,6
the prior year,2
the reversal,2
a previouslyestimated assessment,2
selling,13
total operating,1
the mix,2
international income,2
the effective tax,4
transition,2
the effect,7
total income,3
a reduction,6
federal income,7
the fourth quarter,15
legal settlement,4
the benefit,4
option,12
vesting,1
the significant income,2
the year,5
percentage,2
the mid,1
future,3
new innovative brand,1
the likely increase,1
certain drug,1
the rate,1
conversion,2
downward pressure,1
other thirdparty reimbursement,1
federal government,1
overall market,2
a material impact,9
generic deflation,1
execution,3
the ratable share,2
the assessment,2
each licensee,2
an estimate,7
an appeal,2
the court,3
decision,3
contingency,5
a percentage,12
amortization,22
basis,27
point,3
increase,4
offset,8
the impairment,8
the amortization,3
restructuring,2
transformation,11
acquisitionrelated deal,5
integration,7
see,7
unit,28
annual goodwill,3
impairment assessment,2
other goodwill,2
contribution,5
a startup venture,3
the respective weighted average interest,2
weighted average interest,4
the decrease,4
average,1
invested cash,2
issuance,9
related interest,2
current borrowing,1
the early retirement,7
the debt,2
prepayment,4
an unamortized debt,2
unamortized debt,2
primary,1
strong oncology product,1
the decline,1
the duplicate,1
new information,2
property,7
infrastructure,1
various technology,2
fair,2
foreign currency,7
translation,7
the remeasurement,4
nondeductible legal settlement,1
attributable,8
past experience,1
the application,2
a complete list,1
significant accounting,1
an allowance,3
return,6
full value,2
full credit,2
the time,11
historical customer,1
the allowance,3
the appropriate allowance,2
the aging,2
financial strength,2
standing,2
default,2
history,2
allowance,13
the calculation,2
the required allowance,2
the ultimate realization,3
probable bad debt,2
historical experience,5
specific credit,2
collectability,1
each business,1
a consistent manner,2
the bad debt,1
any period,1
end,3
a rollforward,1
the acquisition,11
the residual,2
thirdparty appraisal,1
the management,2
future cash,1
the reporting,8
a particular operating,2
an operating,7
the similarity,7
the nature,7
regulatory environment,3
a qualitative assessment,2
overall financial performance,2
relevant entityspecific,2
qualitative assessment,2
a reporting,4
a quantitative analysis,2
a qualitative impairment,2
the exception,4
the qualitative assessment,2
the goodwill,2
the quantitative goodwill,2
impairment test,5
no further evaluation,2
no impairment loss,2
the difference,3
the total amount,2
a quantitative impairment,2
an incomebased approach,2
publiclytraded stock,3
the incomebased approach,2
a discounted cash,4
an appropriate discount,2
a sale,2
transaction,7
the annual goodwill,2
depreciation,12
longrange,3
plan,16
the discount,5
the overall aftertax rate,2
a market,2
participant,4
weighted average cost,2
both debt,2
a risk,2
actual future,2
future impairment,2
overall methodology,2
the quantitative impairment,2
test,5
a comparison,2
the indefinitelived intangible asset,2
the asset,8
indefinite,2
the relief,6
royalty,6
method,16
valuation,7
technique,2
the discounted cash,2
a royalty,2
required annual impairment,2
a goodwill impairment,3
annual impairment test,2
recoverability,4
the existence,1
pharmedium,6
initial audit,3
the cgmp,3
several additional longerterm,3
a work,3
an audit,3
inspection,7
certification,3
notification,3
additional audit,3
the district,6
full relief,3
specific relief,3
such petition,3
the specific,3
relief,3
continuous compliance,3
the petition,3
grant,9
such relief,3
impairment loss,3
capacity,6
the likelihood,8
the forecasted cash,5
the related impairment,2
measurement,8
a trade,2
uncertain tax,5
financial reporting,42
net operating,2
a valuation,3
certain deferred tax,2
the required valuation,1
application,1
the valuation,4
the other deferred income,1
file tax,1
interpretation,1
the normal course,2
examination,5
future tax,2
complex tax,1
the tax,6
an uncertain tax,3
the taxing,2
deferred tax,14
reasonable judgment,1
a different estimate,1
the preceding,1
paragraphs,1
the ultimate effective tax,1
a complete discussion,1
the firstin,2
current replacement,2
mix,2
subpoenas government,4
antitrust commercial environmental product,2
intellectual property,4
regulatory employment,3
discrimination,3
a liability,8
the materiality,3
excess,4
an additional loss,3
a reasonable possibility,2
a reasonable estimate,2
the range,4
the preparation,8
a range,3
an adverse judgment,3
the multicurrency,1
the receivables,3
securitization,8
note,11
the overdraft,1
fixedrate debt,1
loan,3
variablerate,1
total debt,1
sufficient capital,1
repayment,2
primary ongoing cash,1
fund,6
the repayment,3
routine growth,1
expansion,1
new business,1
a party,1
a broad resolution,1
opioidlitigation,1
dollar,1
no additional tax,2
build,1
shortterm capital,1
intraperiod,1
shortterm working capital,1
revolving,1
cumulative intraperiod,1
the principal amount,4
an effective yield,4
multicurrency,2
senior unsecured revolving,2
a syndicate,2
an amendment,4
the maturity,4
the alternate base,2
canadian prime rate,2
the total commitment,2
any time,5
a financial leverage,3
ratio,3
indebtedness,2
a commercial paper,2
an aggregate amount,3
the program,2
the date,14
bearing,2
a discount,2
the commercial paper,3
commercial paper,3
an accordion,2
feature,2
the commitment,2
lender,2
approval,5
shortterm commercial paper,2
fee,2
a customary unused fee,2
maturity,1
a revolving basis,2
a whollyowned special purpose,2
entity,4
turn,2
ownership,6
the servicer,2
additional receivables,2
the maximum amount,2
the facility,4
a financing,2
vehicle,2
an attractive interest,2
other financing,2
an uncommitted unsecured line,2
a principal amount,2
the bank,2
prior notice,2
overdraft,2
shortterm normal trading,2
cycle,2
outstanding term,1
variablerate term,2
a rate,2
a base,2
a margin,2
shortterm,2
longterm debt,6
belonging,2
such debt,2
thereon,4
a financial institution,2
the initial payment,2
funded stock,2
holdback,2
the financial institution,2
the volumeweighted average price,2
the term,3
this share,1
a summary,4
minimum,1
noncancelable operating,2
financing,8
the portion,2
future minimum lease,2
the accounting,5
owner,2
the financing,4
obligation,8
noncash termination,2
a onetime transition,3
the transition,5
a sixyear period,2
commitment,1
this liability,1
any future cash,1
reasonable certainty,1
non cash,1
hand,2
an annual average,1
the day,1
the week,1
the month,1
payable outstanding fiscal year,1
a legal settlement,1
plus interest,3
deferred income,5
the deferred income,1
significant capital,1
the construction,2
a new support,1
independent pharmaceutical wholesaler,2
the cash,2
the issuance,5
net cash,2
quarterly dividend,1
fixedrate,1
variablerate debt,5
variable interest,2
the unfavorable impact,1
a hypothetical decrease,1
the favorable impact,1
annual net interest,1
minimal exposure,1
foreign exchange,2
percent,1
consolidated revenue,1
likely outlook,1
forecast,1
intend plan,1
synergy,1
track,2
seek estimate,1
anticipate,1
hereof,1
future performance,1
incorrect,1
frequency,1
prescription drug,1
prosecution,1
suit,2
shareholder,1
federal scrutiny,1
qui tam litigation,1
adverse resolution,2
the retention,1
key customer,1
any contract,1
other dispute,1
supplier payment,1
the strategic longterm,1
the global generic,1
enforcement action,1
the related consent,1
decree suspension,1
continued suspension,1
foreign expansion,1
noncompliance,1
import,1
bankruptcy,2
a major supplier,1
reduction,1
a major customer,1
mix malfunction,1
a charge,2
the inability,2
the expected time,1
the disruption,1
other economic business,1
competitive legal tax,1
i,2
ii,2
iv,2
v,1
no obligation,1
significant market,1
the price,1
discussion,1
consolidated balance,2
comprehensive income,3
financial statement,1
schedule,3
the index,1
opinion,5
all material,6
the financial position,1
internal control,28
framework,3
report,3
an unqualified opinion,2
the responsibility,1
responsibility,2
an opinion,2
audits,1
a public accounting,2
firm,3
the audit,5
reasonable assurance,10
material misstatement,3
performing,2
a test,1
evidence,1
the overall presentation,1
a reasonable basis,2
the critical audit,3
the current period,1
committee,3
the communication,1
critical audit,1
an exposure,1
the possible loss,1
range,2
a statement,1
pain,5
a potential settlement,1
the opioid,4
the potential framework,1
determination,2
a legal contingency,1
significant judgment,2
instance,1
the significant judgment,1
the current status,1
any potential settlement,1
the matter,4
the completeness,3
testing,2
identification,2
recognition,4
external legal counsel,6
accuracy,1
the related financial statement,1
footnote,1
the resolution,1
substantive audit,3
evaluation,3
the probability,3
outcome,1
each material legal contingency,1
understanding,1
relevant history,1
the consistency,1
the balance,4
sheet,5
progress,1
the experience,1
the method,1
estimate,6
the level,1
the combination,1
the determination,2
the type,1
class,4
the regulatory environment,1
aggregation,3
a single reporting,2
the judgment,2
documentation,1
description,2
the financial performance,1
the aggregation,1
the continued suspension,1
a potential consent,1
decree,2
an impairment indicator,1
utilizing,1
undiscounted cash,1
the weighted average,1
the significant estimation,1
the final consent,2
the thirdparty,1
the process,1
the recognition,3
the longlived asset,1
a sensitivity,1
the change,1
significant impact,1
calculation,1
the evaluation,1
the reasonableness,1
current industry,1
s,10
auditor,1
par,8
paidin,1
other comprehensive loss,5
total,1
other income,2
adoption,6
other comprehensive income,2
compensation,15
accelerated share,1
sharebased compensation,8
noncustomer note,1
other loan,2
beginning,1
financial interest,2
the consolidated financial position,1
all intercompany,1
continued reasonableness,1
all income,1
the income,2
statement,3
an employer,1
withholding,1
a policy,1
election,2
annual reporting,3
a cumulative adjustment,1
the establishment,1
a deferred tax,3
the excess tax,1
industryspecific guidance,1
a single comprehensive model,1
principle,5
a company,1
an amount,3
the consideration,1
the entity,1
versus,1
guidance,5
principal versus,1
the guidance,2
a modified retrospective basis,1
the adoption,6
an immaterial impact,1
any material,1
the practical expedient,1
a contract,2
unsatisfied performance,2
an original expected length,1
the variable consideration,1
unsatisfied promise,1
a single performance,1
transparency,1
comparability,1
key information,1
the first quarter,4
retrospective approach,1
package,1
lease identification,1
classification,1
the effective date,2
the hindsight practical expedient,1
the lease term,2
the amended guidance,1
the consolidated balance,1
the present value,1
minimum lease,1
incremental borrowing,1
prepaid,1
the owner,2
a net,1
cumulative adjustment,1
the amended lease,1
amortized cost,1
the net amount,1
the measurement,2
relevant information,1
the collectibility,1
an entity,2
the relevant information,1
estimation,1
a modified retrospective approach,1
a cumulativeeffect adjustment,1
the beginning,3
the first reporting,1
this new accounting,1
a large number,1
the financial condition,5
receivable net,1
collateral,1
reputable credit,1
bear minimal credit,1
the investment,5
the receipt,1
a recovery,1
the antitrust litigation,1
designation,1
the functional currency,1
the applicable local currency,1
the current exchange,1
the weighted average exchange,1
a component,1
each reporting,1
the impairment testing,1
intangible asset,1
the straightline,3
an independent current good manufacturing,1
a method,1
the need,1
some portion,1
the deferred tax,1
probable outcome,1
full disclosure,1
a tax,1
the lastin,1
the variable interest,1
an investment,3
this evaluation,1
initial investment,1
a variable interest,1
the power,1
the entitys economic performance,1
an entitys,1
the voting,3
an ownership,2
noncontrolling interest,3
determinable fair value,1
observable price,1
similar investment,1
the same issuer,1
significant influence,1
the equity,1
construction,1
regardless,1
the significance,1
project,2
a corresponding financing,1
completion,1
a saleleaseback,1
the related financing,2
the life,1
the related lease,1
a straightline basis,3
the expected lease term,1
the related inventory,1
machinery,1
maintenance,2
computer,1
internal use,1
the project,1
stage,2
preliminary stage,1
all other postimplementation,1
a point,1
title,1
no further obligation,1
a transaction,2
therefore,1
a gross basis,1
the product,3
a customer,3
the promise,1
discretion,1
a distribution,1
other customer,1
historical return,1
the compensation,1
a binomial option,2
the grant,4
the requisite service,4
the same line,1
item,1
nonvested performance,3
periodic assessment,2
pick pack,1
various price,1
these reserve,1
the specific incentive,1
any other pertinent information,1
a continual basis,1
the reserve,2
appropriate,1
the ultimate outcome,1
any outstanding claim,1
an independent regional distributor,1
the northeast region,1
future animal,1
the net tangible,4
receivable inventory,4
useful life,3
new longterm debt,1
fullline distribution,1
generic,1
highvalue,1
strategic scale,1
a tradename,2
the tradename,1
a noncontrolling ownership,1
a leading pharmaceutical wholesaler,1
a joint venture,1
the brazilian marketplace,1
the additional investment,1
substantial governance,2
majority,1
an additional investment,2
the noncontrolling interest,1
an agreedupon,1
shortterm debt,2
a noncontrolling interest,1
the consolidation,2
the incremental ownership,1
these represent level,1
a pretax loss,1
this investment,1
economic performance,1
future financial support,1
recourse,1
the general credit,1
the following table,1
current provision,2
local income,1
federal tax,2
a reconciliation,1
effective income,1
corporate tax,1
new international tax,1
staff,2
a oneyear measurement,1
a deferred income,1
the fiscal quarter,14
an income,1
the oneyear measurement,1
foreign cash,1
further assessment,1
the future tax,1
the following tax,1
carryforward,1
potential tax,3
federal net operating,1
foreign net operating,2
federal alternative minimum tax,1
foreign alternative minimum tax,1
negative evidence,1
this assessment valuation,1
a legislative change,1
select net operating,1
this decrease,1
the additional valuation,1
the utilization,1
the exercise,1
federal jurisdiction,1
foreign income,1
the aggregate tax,1
the unrecognized tax,1
reconciliation,1
unrecognized tax,7
civil litigation,1
reserve,1
this reserve,2
a payment,2
this litigation,1
the settlement,8
an estimated purchase,1
current portion,2
nonrecourse current portion,1
total net,1
borrowing,1
noninterest bearing,1
pari passu,1
the stated interest,1
the table,1
additional indebtedness,1
the repurchase,1
the making,1
preferred stock,19
creation,1
an additional covenant,1
nonrecourse debt,1
the above indebtedness,1
total amortization,1
the accretion,1
original issue,1
the authorized capital,1
the preferred stock,1
the board,11
series,2
no voting,1
the respective series,1
the same dividend,1
vote,3
the exclusive right,2
a per,2
the weighted average number,2
the dilutive effect,1
outstanding basic effect,1
dilutive stock,1
outstanding common stock,1
a related party,1
a pharmaceutical distribution,1
favorable economic pricing,1
a generic purchasing,1
various retirement,1
a deferred compensation,1
the administration,1
retirement,1
other benefit,1
an internal committee,1
senior finance,1
the plan,3
a defined contribution,1
regular compensation,1
the participant,5
salary,1
an additional discretionary contribution,1
an expense,1
a discretionary contribution,1
the direction,1
the employee,2
credited service,1
this unfunded plan,2
key management,2
total cash,3
the annual compensation,3
limit,4
this plan,2
an annual amount,2
annual compensation,1
dividend,3
fractional number,1
the average,1
each full share,1
the deferred compensation,1
deferred compensation,1
the granting,2
nonqualified stock,2
the fair market,2
the option,1
a fouryear service,1
expire,2
director,4
a threeyear service,1
nonemployee director,1
the estimated fair value,1
the historical volatility,1
implied market,1
historical exercise,1
yield,1
life,1
curve,1
activity,1
related information,1
exercise,1
contractual term,1
the intrinsic value,1
expected future compensation,2
a weighted average period,2
certain executive,1
represent common stock,1
the end,4
a threeyear performance,1
achievement,1
specific performance,1
the target,2
award,3
target,1
the threeyear performance,1
rental expense,1
total minimum lease,1
relating,2
deal,3
total employee,1
the organization,2
legacy,1
antitrust commercial product,1
a reserve,2
conduct,1
corporate integrity,1
consent,3
the dispute,1
attempt,1
other outcome,1
any subsequent reporting,1
that period,1
significant number,1
putative class,1
controlled substance,3
common law,1
negligence public nuisance,1
unjust enrichment,1
seek,1
equitable relief,1
an initial group,1
a motion,2
a friend,1
an order,3
a litigation,1
dispositive motion,1
practice,2
discovery,3
a second bellwether,1
motion,2
the second set,1
bellwether,1
the first track,1
prejudice,4
courtordered settlement,1
a potential framework,1
announcement,1
portion,1
the development,1
rebated distribution,1
opioidabuse,1
antidiversion,1
the same goal,1
the finality,1
prepare,1
significant uncertainty,1
the inherent uncertainty,1
such litigation,1
a position,2
the likely outcome,2
possible loss,1
a procedure,1
a nationwide negotiation,1
the nationwide manufacturing,1
the motion,2
the trial,3
that order,1
a subsequent meeting,1
intent,1
these government,1
alleging,1
illegitimate,1
other equitable relief,1
this matter,1
a settlement,1
express denial,1
any wrongdoing,1
various government,2
cgmp,1
the authority,2
deny,1
reciprocal state,1
shipping,1
a subpoena,1
the subpoena,1
a notice,1
investigation,1
counsel,1
the relator,1
further consideration,1
the prefilled syringe,1
certain oncology,1
a plea,1
a guilty plea,1
a onecount,1
strictliability,1
misdemeanor violation,1
the agreement,2
a total criminal fine,1
forfeiture,1
the guilty plea,1
the federal criminal investigation,1
register,1
entirety,2
potential administrative action,1
dismissal,1
the maintenance,3
a compliance,1
an independent review,1
a financial recoupment,1
the civil litigation,1
any admission,1
matter,1
the manufacturer,2
that product,1
any state,1
probable note,1
concert,1
a plaintiff,1
a member,1
the past,1
attorney,1
the chief,1
maker,1
function,1
the elimination,1
total segment,2
expense net loss,1
corporate office,1
the suspended production,1
these remediation,1
stability,1
total depreciation,1
deferred financing,1
approximate fair,1
shortterm nature,1
the money,1
the recorded amount,2
the corresponding fair value,2
include,5
third quarter,1
a previous estimate,1
adjustment,1
the onetime transition,1
the second quarter,2
a gain,1
the third quarter,1
discrete income,1
that information,2
the participation,1
such term,1
adequate internal control,1
the reliability,4
reasonable detail,2
preparation,2
iii provide,1
prevention,2
timely detection,2
unauthorized acquisition,2
disposition,2
a material effect,2
any evaluation,2
the degree,2
this assessment management,1
public accounting,1
an attestation,1
effective internal control,3
criteria,1
an understanding,1
weakness,1
the design,3
companys internal control,1
a process,1
companys,1
pertain,1
provide,2
the companys,1
the close,1
copy,1
amendment,3
any provision,2
list,2
the following financial statement,1
the applicable accounting,1
indenture,1
trustee,15
exhibit,8
originator,6
buyer,5
party,19
seller,14
servicer,13
the various purchaser,1
administrator,13
the purchaser,8
assignee,2
guarantor,4
favor,1
recipient,1
the borrowing,1
ixbrl,1
inline,1
any security,1
holder,1
the reasonable cost,1
reproduction,1
each marked exhibit,1
a management,1
a compensatory,1
a director,5
executive officer,1
the undersigned thereunto,1
duly,1
thousand,2
the following description,1
certificate,29
an exhibit,1
this exhibit,2
a part,2
consisting,1
authorized common stock,1
each outstanding share,1
a certificate,1
the election,1
cumulative voting,2
involuntary liquidation,1
dissolution,1
no right,1
no redemption,1
no liability,1
reason,1
own conduct,1
liquidation,1
the holder,1
authorized preferred stock,1
any series,1
such series,2
any designation,1
a premium,1
the same time,1
the summary,1
bylaws,6
that preferred stock,1
such designation,1
defer,1
prevent,1
any attempt,1
the next election,1
the composition,2
any election,1
special meeting,3
a resolution,1
other business,2
an annual meeting,1
the anniversary,1
previous annual meeting,1
the notice,1
specific information,1
the nominee,1
the stockholder,2
the nomination,1
alter amend,1
the bylaws,2
the assent,1
alter,1
amend,1
the affirmative vote,2
alteration,2
repeal,1
present,1
person,2
proxy,1
a meeting,1
an interested stockholder,7
the person,1
an aggregate market,1
the corporation,2
the interested stockholder,6
a person,2
this prohibition,1
consummation,1
specified employee,1
the outstanding voting,1
the accomplishment,1
other takeover,1
changeincontrol,1
a companys board,1
a corporation,1
an election,1
the liability,1
the personal liability,1
exculpation,1
any breach,1
duty,1
loyalty,1
good faith,1
intentional misconduct,1
a knowing violation,1
the unlawful payment,1
any transaction,1
the director,1
an improper personal benefit,1
any person,1
officer,8
ours,1
request,2
another corporation,1
trust,2
other enterprise,2
such person,2
any capacity,1
such other corporation,1
the full extent,1
hereafter,1
such right,1
any action,4
final disposition,1
the limitation,1
indemnification,1
advancement,1
a lawsuit,1
fiduciary duty,1
derivative litigation,1
an action,1
these indemnification,1
an alternative forum,1
the sole,1
exclusive forum,1
any derivative action,1
a claim,3
a fiduciary duty,1
each case,1
doctrine,1
subject matter,1
jurisdiction,2
another state,1
no state,1
the federal district,1
an interest,1
the registrar,1
the incorporation,1
the following registration,1
pertaining,1
certify,2
knowledge,6
any untrue statement,2
a material fact,2
omit,2
fact,2
light,2
other financial information,2
such disclosure,4
supervision,4
material information,2
prepared b,2
such internal control,4
such evaluation,2
any change,2
recent fiscal quarter,2
fourth fiscal quarter,2
an annual report,2
recent evaluation,2
summarize,2
financial information,2
a significant role,2
this certification,1
including area,1
is a wellknown seasoned issuer,1
accelerated filer,4
emerging growth,3
reporting company,1
use the extended transition,1
revised financial accounting,1
is a shell,1
voting stock,3
improve patient access,3
enhance patient care,2
increase the effectiveness,2
distribute a comprehensive offering,1
including acute care,1
mail order,4
alternate site,4
impact the growth,1
growing segment,1
ongoing research,2
used brandname,1
increased emphasis,1
managed care,2
consider the increase,1
reduce revenue,1
rising healthcare,1
adopted cost,1
encourage the use,1
believe drug,1
had a beneficial impact,1
continued emphasis,1
continuing introduction,1
existing drug,1
enacted major health,1
expand access,1
increased the number,1
costs the health,1
including drug,2
expanded disclosure,1
enhanced enforcement authority,1
prevent fraud,1
offer a broad range,2
enhance the efficiency,1
improve the delivery,2
provide valueadded distribution,1
pharmacies health,1
improve channel,1
focused strategy,1
grow revenue,1
increase operating,2
including specialty,1
provide superior distribution,1
deliver value,1
improve the efficiency,1
allowing the pharmaceutical supply,1
deliver healthcare,1
are a leader,1
offer a valueadded generic formulary program,1
include assistance,1
accelerate product,1
enables independent community,1
includes a national distribution,1
increased productivity,1
operating income,20
implement warehouse,1
increasing volume,1
consulting service,1
supporting access,1
staffing patient assistance,1
copay assistance,1
risk mitigation,1
leading global specialty,4
established platform,1
micro feed,4
doing business,1
divested certain noncore,1
require separate reportable segment,3
provide drug,1
reduce healthcare,1
improve patient,1
distributes a comprehensive offering,3
including acute,3
provides pharmaceutical distribution,3
including plasma,3
provides pharmacy,3
supply management,3
provides a full suite,3
leading animal health,3
marketing the majority,1
has support,1
serve national account,1
receiving service,1
have an enterprisewide marketing,1
have a diverse customer,1
include acute care,2
longterm care,3
enhance the operating,1
affect future revenue,1
be the primary source,1
operate the majority,1
upgrade the operating,1
drive efficiency,1
automated warehouse,1
regulate the pharmaceutical supply,2
strengthen customer,1
reduce operating,1
providing a platform,1
including product,2
processing realtime price,1
processes a substantial portion,1
manage the majority,1
related healthcare,1
face competition,1
include price,1
valueadded service,1
use a number,1
are the subject,1
processes software,1
facilitate the conduct,1
protect such intellectual property,1
dispensing equipment,2
seek patent protection,1
assert infringement,1
existing collective bargaining,1
have adequate contingency,1
assure delivery,1
compounding purchase,1
meet various security,2
governing the sale,2
have broad enforcement,3
including the ability,1
reached an agreement,6
completed audit,2
suspended production,7
continue the ongoing compliance,1
resume commercial distribution,2
including the federal antikickback,1
offering receiving,2
paying any remuneration,2
induce the purchasing,1
induce a referral,1
purchase lease,1
causing the submission,1
protect the safety,2
prevent the introduction,1
became law,2
establishes federal traceability,2
require all supplychain,2
including licensing,2
licensed thirdparty,2
governing wholesale distributor,1
achieve compliance,2
be no assurance,10
increase the cost,1
governing the production,1
have a material adverse effect,15
have a significant impact,1
set forth privacy,1
protect the privacy,1
collect maintain,2
strengthened federal privacy,1
governing protected health,1
imposed new notification,1
including sensitive personal information,1
protecting such information,1
implemented a privacy,1
describes certain risk,1
set forth elsewhere,1
consider this list,1
be a complete statement,1
experience unfavorable brand,1
have an adverse effect,2
use wholesale acquisition,1
sell brand,1
negotiated contract,1
are a number,2
impact wac list,1
have a price,1
accelerates the negative impact,1
increasing consolidation,1
have a material,1
bargaining power,1
including state,1
regulate the pharmaceutical distribution,1
prevent diversion,1
adulterated andor,1
include operating,1
issue draft,1
considering legislation,2
reimbursement pricing,1
declining reimbursement,2
reducing reimbursement,1
changing the methodology,1
regulating pricing,1
been the subject,1
impacting pharmaceutical pricing,1
broadening healthcare access,1
continuing implementation,1
predict the impact,2
have an adverse impact,3
mitigate the impact,2
sell specialty,1
published a final rule,2
proposed calendar,1
including a reduced rate,1
including a potential proposal,1
modify distribution,1
affect the structure,1
affecting drug,1
require drug,1
provide advance,1
report information,1
establish prescription,1
reduce the cost,1
allow importation,1
healthcare fraud,2
involving healthcare,2
induce the referral,1
impose a number,1
designated health,1
increased funding,1
suspected fraud,1
including the loss,1
regarding the distribution,4
indicated an intent,1
diversion control,1
warranting further review,1
ongoing monitoring,1
involved the complexity,2
achieving a potential global resolution,2
predict the outcome,7
andor injunctive relief,2
address the misuse,1
instituted an opioid excise,1
make the initial sale,1
enacted increased licensure,1
pay an assessment,1
assesses the sale,1
permitted such legislation,1
including the distribution,1
any settlement,1
form the basis,1
complaints the qui,1
authorize a private person,1
acts the filing,1
has a fiveyear term,2
purchasing organization,2
lose a significant customer,2
existing contract,2
expiration each year,2
extend renew renegotiate,1
provides a variety,1
negotiating acquisition,1
continued cost,1
exploring innovation together,1
including the potential inability,1
realize andor,1
including improved generic drug,1
improved service,1
expected the potential disruption,1
extended the duration,1
including any disruption,1
return value,2
has the right,3
open market,1
prevailing market,5
decreased revenue,1
have a material adverse impact,4
are the primary distributor,1
have an obligation,1
existing distribution,1
are a large corporation,1
existing precedent,1
regarding the geographic mix,1
made the suspension,1
purchase compound,1
issue a registration,1
governing distribution,1
regulate the distribution,1
preventing the illegal diversion,1
ensure compliance,1
i the ability,1
detect the illegal diversion,1
require time,2
outsourcing facility,1
resumes commercial distribution,1
requested information,1
concerning the status,1
received a warning,1
including a failure,2
andor license revocation,1
freestanding hospital,1
including quality,1
labeling flaws improper packaging,1
regarding a quality,1
reduce market,1
represent a class,1
establish multidistrict litigation,1
any such action,1
prove insufficient,1
cover any liability,1
obtain insurance,1
satisfy any liability,1
make public disclosure,1
including litigation,1
risks the fair value,1
pending the imposition,1
ongoing the review,1
includes consideration,1
encounter difficulty,1
delay the achievement,1
objectives the impact,1
conduct business,2
create substantial liability,1
cause a loss,2
retaining business abroad,1
obtaining favorable treatment,1
maintain an adequate system,1
receive export,1
including inflation,1
experience significant disruption,1
experience downward movement,1
be material,1
existing credit,1
meet certain financial performance,1
including any announcement,1
assigned a negative outlook,1
provide credit,1
give rise,1
pending litigation,1
affect the solvency,2
has a substantial account,1
obtain a security,1
has a substantial amount,1
is uncertainty,1
maintain liquidity,1
raises substantial doubt,1
going concern,2
continue the relationship,1
facilitate the purchase,1
receive process,1
manage the accurate billing,1
managing a portion,1
increased sophistication,1
continued development,1
remain a priority,1
have robust information,1
remediate any information,1
regulate the collection,1
record a further significant charge,2
accepted accounting,10
expected operating,1
carrying value,21
considered a change,1
compounding facility,8
performed a recoverability,3
recorded an impairment loss,1
meet business,1
affect the accuracy,2
andor disruption,1
provide protection,1
affect the availability,1
do business,2
affect the amount,1
cause a decrease,2
including interest,2
obtain credit,2
reduce discretionary spending,1
incur bad debt,1
has a robust distribution,1
is a list,2
joining the company,1
held various leadership,1
increased the quarterly dividend,2
pay quarterly cash,2
forth the total number,1
purchased the average price,1
authorized a share,3
allowing the company,4
authorized a new share,3
including reinvestment,1
estimated assessment,3
contained herein,1
support the increase,1
changed the mix,2
biosimilars the likely increase,1
increased downward pressure,1
continued strong specialty,1
including group,1
have a material impact,9
pending execution,3
incur remediation,1
ceased production,1
ratably source,2
filed an appeal,2
believe a loss,2
support revenue,2
consulting business,5
intangibles amortization,3
excluding gain,2
vesting net income,2
increased revenue,1
consulting group,4
held equity,5
held interest,1
involve accounting,1
require the use,2
presented net,1
estimated customer,3
trends the allowance,1
determining the appropriate allowance,2
consider a combination,1
requires judgment,2
ongoing credit,2
forth a rollforward,1
engage thirdparty appraisal,1
assist management,1
require management,1
expected future cash,1
existing technology,1
include the similarity,3
perform a qualitative assessment,2
perform a quantitative analysis,1
perform a qualitative impairment,2
performing the qualitative assessment,2
carrying amount,2
exceeds the fair value,2
exceed the total amount,2
performing a quantitative impairment,2
utilize an incomebased approach,1
estimated control,2
forecasted cash,2
determine the fair value,4
reporting unit,1
use a discounted cash,2
make a number,2
working capital,6
is an estimate,2
includes both debt,2
including a risk,2
andor market,2
recorded goodwill,2
changing business,2
testing date,1
estimate the fair value,1
using the relief,2
believe the relief,1
used valuation,2
pay a royalty,2
recorded a goodwill impairment,3
perform a recoverability,1
assess the effectiveness,3
include a work,3
written notification,3
petition the district,3
seeking relief,3
been continuous compliance,3
oppose the petition,3
estimating the fair value,2
ii the period,3
resume production,3
considering the likelihood,3
estimate fair value,2
measure the related impairment,2
nonrecurring fair value,4
estimated future,1
established a valuation,1
applying complex tax,1
recognize the tax,1
applying reasonable judgment,1
develop a different estimate,1
change an increase,1
caused income,1
used the firstin,2
approximates current replacement,2
including antitrust commercial environmental product,2
record a liability,1
perform an assessment,1
provide disclosure,1
estimate a range,3
negotiated resolution,3
consolidated financial position,2
including availability,1
revolving credit,9
generated cash,1
provided sufficient capital,1
fund capital,1
ongoing cash,1
are a party,1
remaining opioidlitigation,1
fund shortterm capital,1
cover shortterm working capital,1
have an effective yield,4
finance the early retirement,2
including the payment,2
finance the acquisition,2
extend the maturity,4
pay facility,1
maintain the availability,4
including compliance,2
have a commercial paper,1
bear interest,2
amounts the commercial paper,2
borrowing capacity,1
whereby the commitment,2
pay a customary unused fee,1
scheduled maturity,1
sells a percentage,2
is the servicer,2
collected additional receivables,2
use the facility,1
offers an attractive interest,2
have an uncommitted unsecured line,1
fund shortterm normal trading,2
bears interest,2
total the following,1
is a summary,4
be the accounting,2
exclude the future,2
requires a onetime transition,1
represents an estimate,1
estimated liability,1
provided cash,2
was the result,2
affect the number,1
working capital additionally,1
operating cash,3
statements the increase,1
included technology,1
expanding distribution,1
included the early retirement,1
following quarterly dividend,1
have market,2
manage interest,1
using a combination,1
have minimal exposure,1
utilize foreign currency,1
expect likely outlook,1
project intend plan,1
sustain synergy,1
believe seek estimate,1
prove incorrect,1
increasing pressure,1
impact prescription drug,1
regarding the pharmaceutical supply,1
continued prosecution,1
achieve a global resolution,1
including shareholder,1
increased federal scrutiny,1
including qui tam litigation,1
governing the marketing,1
including continued suspension,1
managing foreign expansion,1
including noncompliance,1
including the integration,1
related thereto,1
divestitures the disruption,1
set forth,3
undertakes no obligation,1
changing interest,1
accompanying consolidated balance,1
respects the financial position,1
expressed an unqualified opinion,2
are the responsibility,1
express an opinion,2
are a public accounting,2
perform the audit,2
obtain reasonable assurance,2
evaluating the accounting,1
evaluating the overall presentation,1
provide a reasonable basis,1
communicating the critical audit,1
recognizes a liability,1
performs an assessment,2
discloses the nature,1
including the company,2
regarding a potential settlement,1
litigate the opioid,1
recognized a liability,2
requires significant judgment,1
determining the likelihood,1
given the current status,1
addressed the matter,3
included testing,1
including the opioid,1
determine the completeness,1
testing the completeness,1
evaluate the consistency,1
considered the litigation,1
estimate the range,2
evaluated the method,1
tests goodwill,1
requires the company,3
processes the type,1
longlived asset,2
i the similarity,1
ii the similarity,1
iii the similarity,1
iv the similarity,1
including the financial performance,1
assess the aggregation,1
recognized an impairment loss,1
regarding a potential consent,1
identifying an impairment indicator,1
represented the amount,1
estimated fair value,5
determining the fair value,1
i the discount,1
estimated revenue,1
evaluate the change,1
involved valuation,1
including the evaluation,1
compared the forecasted cash,1
assess the forecasted cash,1
recover asset,1
accumulated depreciation,1
restricted transaction,1
restricted share,3
reconcile net income,1
controlling financial interest,2
enhance patient,1
improve the effectiveness,1
present the consolidated financial position,1
indicated all intercompany,1
requires management,1
requires all income,1
allows an employer,1
triggering liability,1
make a policy,1
supersedes the revenue,1
outlines a single comprehensive model,1
recognize revenue,1
depict the transfer,1
reflects the consideration,1
clarified the implementation,1
amended the guidance,1
identifying performance,1
had an immaterial impact,1
flows the company,1
record any material,1
deferred contract,1
elected the practical expedient,1
obtain a contract,1
disclose the value,1
recognizes revenue,2
forms part,1
increase transparency,1
regarding lease,1
modified retrospective approach,1
elect the transition,1
amended guidance,1
reassess lease identification,1
combine lease,1
elect the hindsight practical expedient,1
determining the lease term,1
finalize the impact,1
remaining minimum lease,1
deemed the owner,2
finalizing the impact,1
collected the measurement,1
expected credit,1
including historical experience,1
affect the collectibility,1
use judgment,1
determining the relevant information,1
evaluating the impact,1
adopting this new accounting,1
issued accounting,1
acquired business,1
approximates fair value,1
be cash,1
veterinarians the financial condition,1
require collateral,1
considers a combination,1
maintains cash,1
exceed the amount,1
monitoring the risk,1
mitigate risk,1
monitoring the investment,1
resolve the company,2
records a liability,1
provides disclosure,1
contingencies the company,1
represent a recovery,1
were the subject,1
is the applicable local currency,1
using the current exchange,1
resulting translation,1
performs a quantitative analysis,1
utilizes an incomebased approach,1
estimates the fair value,2
believes the relief,1
lived intangible asset,1
using the straightline,3
performs a recoverability,1
cgmp expert,1
using a method,1
requires recognition,1
expected future tax,1
assessing the need,1
establish a valuation,1
recognizes the tax,1
met the recognition,1
using the lastin,1
is a variable interest,1
impact the entitys economic performance,1
absorb an entitys,1
holds an ownership,1
uses the fair value,1
exercise significant influence,1
uses the equity,1
total project,1
project the company,1
performs a saleleaseback,1
represent product,1
capitalizes project,1
reach the application,1
training maintenance,1
include clinical trial,1
disaggregated revenue,1
is no further obligation,1
is the principal,1
controls the ability,1
direct the use,1
fulfilling the promise,1
provide the product,1
has discretion,1
establishing pricing,1
controls the relationship,1
confirmed purchase,1
allowances other customer,1
records an asset,1
using a binomial option,2
issued the income,1
warehouse pick pack,1
deliver inventory,1
considering the status,1
adjusts the reserve,1
was an independent regional distributor,1
exceeded the fair value,4
goodwill the fair value,4
estimated useful life,3
funded the acquisition,1
provides fullline distribution,1
amortizing the fair value,1
established a deferred tax,2
held a noncontrolling ownership,1
provide specialty,1
received substantial governance,1
consolidating the operating,1
consolidate the operating,1
made an additional investment,2
including the noncontrolling interest,1
obtaining control,1
consolidated shortterm debt,2
recorded a noncontrolling interest,1
amortizing the customer,1
obtained substantial governance,1
consolidated the operating,1
provide future financial support,1
have recourse,1
following table,1
indicated fiscal year,3
consolidated income,1
deferred provision,1
consolidated effective income,1
included a broad range,1
issued guidance,1
regarding the accounting,1
recognized income,1
completed the accounting,1
recognized an income,1
is net,1
reflect the future tax,1
operating loss,1
varying expiration,1
decreased the valuation,2
enable the company,1
utilize select net operating,1
file income,1
reduced income,1
ending amount,1
excluding interest,1
made a payment,2
resolve this litigation,1
pays facility,1
has a commercial paper,1
pays a customary unused fee,1
is a financing,1
has an uncommitted unsecured line,1
provides the company,1
rank pari passu,1
stockholders the repurchase,1
requires compliance,1
outstanding the authorized capital,1
have no voting,1
have the exclusive right,2
accumulated other comprehensive loss,1
dividing net income,2
considered a related party,1
including a pharmaceutical distribution,1
sponsors various retirement,1
delegated the administration,1
plans the company,1
is a defined contribution,1
recognized an expense,1
selected key management,1
contributed an amount,1
exceeded the annual compensation,1
exceeds the annual compensation,2
defined contribution,1
defer a portion,1
including dividend,1
granted option,1
uses historical exercise,1
expected dividend,1
yield curve,1
granted fiscal year,1
recognized stock,1
recognized restricted stock,1
nonvested restricted stock,1
recognized performance,1
recorded rental expense,1
align the organization,2
servicing legacy,1
existing company,1
reorganizing the company,1
needs the majority,1
including antitrust commercial product,1
records a reserve,1
litigate the dispute,1
settle the matter,1
noted the amount,1
including negligence public nuisance,1
granted a motion,1
providing information,1
issued an order,2
creating a litigation,1
includes dispositive motion,1
track the timing,1
announced an agreement,1
recorded a charge,1
oversee courtordered settlement,1
proposed settlement,1
provide a potential framework,1
pay an aggregate amount,1
reaching a global resolution,1
achieve an agreement,1
provide the finality,1
given the large number,1
therefore a global resolution,1
given the inherent uncertainty,1
assess the likely outcome,2
filed a motion,1
proposing a procedure,1
certify a nationwide negotiation,1
withdrew the motion,1
amended motion,1
granted the motion,1
entered an order,1
accelerating the trial,1
amended the trial,1
filed suit,1
requesting the production,1
request the production,1
regulate the compounding,1
determine compliance,1
including the authority,1
revoke limit,1
suspended shipping,1
received a subpoena,1
informed the company,1
filed a notice,1
filed qui,1
amended complaint,1
requesting production,1
entered a guilty plea,1
paid a total criminal fine,1
resolves the federal criminal investigation,1
duly register,1
resolved potential administrative action,1
obtained dismissal,1
resolve the civil litigation,1
making any admission,1
accrued a reserve,1
disclosed matter,1
involving the dispensing,1
had the authority,1
recognized this reserve,1
is probable note,1
entering the market,1
named a plaintiff,1
been a member,1
are net,1
operating decision,1
assess the performance,1
operating segment,1
represent the elimination,1
exclude impairment,1
incurred remediation,1
assessing performance,1
amortization total depreciation,1
includes depreciation,1
excludes amortization,1
inputs the recorded amount,1
includes a gain,1
includes a loss,1
included discrete income,1
maintains disclosure,1
ensure that information,2
evaluated the effectiveness,3
maintaining adequate internal control,1
provide reasonable assurance,5
regarding the reliability,4
permit preparation,2
regarding prevention,2
have a material effect,2
assessed the effectiveness,1
making this assessment management,1
registered public accounting,1
issued an attestation,1
subsidiaries the company,1
maintaining effective internal control,1
obtaining an understanding,1
assessing the risk,1
evaluating the design,1
operating effectiveness,1
assessed risk,1
provides a reasonable basis,1
is a process,1
deteriorate s,1
including information,5
incorporated herein,5
servicer the purchaser,1
is a management,1
caused this report,1
describes the common stock,1
registered pursuant,1
amended the following description,1
restated certificate,1
is a part,2
issue a total,1
have cumulative voting,1
are no redemption,1
sinking fund,1
have no liability,1
authorize the issuance,1
voting conversion,1
issue preferred stock,1
have the effect,3
realize a premium,1
set the voting,1
delay defer,1
hold office,1
change the composition,2
written consent,1
scheduled annual meeting,1
call special meeting,1
give notice,1
contain specific information,1
regarding the nominee,1
regarding the stockholder,1
proposing the nomination,1
make alter amend,1
repeal the bylaws,2
make alter,1
repeal section,1
became an interested stockholder,1
having an aggregate market,1
becoming an interested stockholder,2
becomes an interested stockholder,2
delay the accomplishment,1
eliminate the personal liability,1
permit exculpation,1
involve intentional misconduct,1
derived an improper personal benefit,1
indemnify any person,1
was a director,1
be a director,1
defending any action,1
bringing a lawsuit,1
reducing the likelihood,1
asserting a claim,3
iii any action,1
arising pursuant,1
iv any action,1
has jurisdiction,1
acquires an interest,1
have notice,1
transfer agent,1
contain any untrue statement,2
respects the financial condition,4
certifying officer,4
maintaining disclosure,2
designed such disclosure,2
caused such disclosure,2
being prepared b,2
designed such internal control,2
caused such internal control,2
record process,2
report financial information,2
involves management,2
have a significant role,2
certify pursuant,2
adopted pursuant,2
written statement,1
number including,1
the registrant is,3
the registrant is not,1
the registrant was,2
the registrant has,2
company see,1
filer accelerated filer,1
company indicate,1
stock held,2
the following document are,1
this report indicated,1
equipment outsourced,4
healthcare industry are,1
rate is,4
total healthcare expenditures,1
therapy continue,1
business increased,1
addition increased,1
containment measures,1
national attention has,1
aggregate healthcare costs,1
therapy has,1
development is,1
the federal government enacted,1
legislation designed,1
drug costs,1
law provides,1
industry enhanced,1
the pharmaceutical supply channel,2
strategy is,1
unified way has,1
value added,2
the generic marketplace including,1
program based,1
rapid new product launches,1
pharmacy consulting,1
network includes,1
field staffing,1
time consider,1
reportable segment distributes,3
reportable segment provides,6
pharmaceutical distribution including,3
force is,1
the fiscal year ended,119
supply are,1
fiscal year ended,13
segment operates,1
inventory tracking,1
the warehouse operating,1
business have,1
automated pharmacy dispensing,1
supply dispensing,1
marketing compounding,1
a consent decree,4
any way paid,2
counterfeit diverted,1
legislation known,2
regulation governing,1
andor access protected,1
other personal information including,1
identifiable information is also,1
business are,3
the website are not,1
the following discussion describes,1
fluctuation based,1
deflation accelerates,1
section beginning,1
industry has,1
consolidation including,1
pharmacy compounding,1
pharmaceutical distribution is,1
counterfeit adulterated,1
andor mislabeled,1
cgmps are,1
litigation related,1
regulation impacting,1
legislation has,1
cause corresponding,1
this policy exceeded,1
process is still,1
business including,1
information relating,1
the federal government continues,1
fraud affecting,1
chain including,1
litigation described,1
deployment including,1
capital returned,1
tam complaints,1
a private person known,1
a relator imposes,1
the litigation proceeds,1
group purchasing,2
such early termination is,1
cash flows,7
an ongoing basis is,1
agreement including,1
revenue decreased,1
generic pharmaceutical program has also,1
arrangement does not,1
legislation resulting,1
thereof including,1
packaging compounding,1
time investigate,1
iii impose,1
the future receive,1
facility located,7
facility resumes,1
information concerning,1
time issue,3
regulatory authority including,1
business sells,1
safety alert,1
publicity including,1
reputational harm resulting,1
death caused,1
litigation risks,1
the review includes,1
difficulty finding,1
acquisition described,1
foreign policy including,1
the supplier has,1
a substantial amount owed,1
the quarter ended,5
uncertainty regarding,1
facility is,1
indebtedness thereunder is,1
the foregoing including,1
this customer was approximately,1
center interruptions,1
provider does not,1
reputation increase,1
unauthorized access remain,1
security measures,1
goodwill indefinitelived,2
the testing required,1
group exceeded,3
business do not,1
the following is,6
common stock is,3
the average price paid,1
repurchase program allowing,6
the company purchased,7
cash settled,8
this program c,1
this graph depicts,1
the graph assumes,1
capitalization consists,1
index including,1
share amounts,1
share diluted,1
assessment related,3
c includes,1
d includes,1
e includes,1
expense of0,1
summary provides,1
gross profit increased,3
facility has,2
the current fiscal year was favorably,2
a previouslyestimated assessment related,2
income decreased,2
tax related,2
charge was,3
share were significantly,2
benefit recognized,2
year ended,3
the year ended,4
growth trends,1
segment grew,2
revenue increased,3
such customer expires,1
remediation costs,8
profit increased,2
antitrust litigation settlements,1
the current fiscal year was primarily,1
inflation offset,1
each licensee was,2
contingency is,2
the current fiscal year remained relatively,1
the current fiscal year decreased,1
increase compared,2
expense increased,3
expense decreased,1
segment operating,5
income is,3
income increased,1
margin decreased,2
receivable related,3
net decreased,1
the prior fiscal year was,1
the debt included,2
issuance costs,2
stock vesting,2
profit was negatively,1
the prior fiscal year was primarily,4
equipment placed,1
service relating,1
impairment operating,1
group offset,1
expense net increased,1
fair values,1
interest see,1
management believes,2
the customer based,2
return trends,1
the required allowance requires,2
trade receivables,2
collectability is,1
expense was,2
any period presented,1
a business are,1
price allocated,1
fair value based,1
information obtained,1
company resides,2
structure beginning,2
production processes,2
unit is less,2
impairment test requires,4
the fair value exceeds,2
no further evaluation is,2
no impairment loss is,2
amount exceeds,2
the fair value is,2
goodwill allocated,2
growth operating,2
return required,2
capital includes,2
equity including,2
indefinite lived,2
method is,4
the fair value derived,2
pharmedium reached,3
expert has,3
plan approved,3
relief have,3
group was,4
group is,2
group included,3
the related impairment are inherently,2
expense deferred,1
law resulting,1
judgment is,1
paragraphs are,1
provision is,3
a loss has,2
the amount is reasonably,3
a loss is,5
an additional loss has,2
loss has,2
the loss contingencies,2
the multicurrency revolving,1
fund repurchases,1
dollar denominated,1
position is,1
cash held,1
shortterm capital needs,1
shortterm working capital needs,1
rating ranging,2
time amounts,2
face amounts,2
program does not,2
feature whereby,2
turn sells,2
rate relative,2
note revolving,2
debt is,1
thereon is,2
transaction was,2
the financial institution delivered,2
availability remaining,1
owner see,2
liability related,1
tax is,1
a sixyear period commencing,2
commitment is,1
this liability represents,1
liability has,1
receivable was,2
the month ends,1
payable outstanding fiscal year ended,1
period based,2
end working,1
plus interest see,1
benefit was primarily,1
net deferred,2
various technology initiatives,1
the cash used,1
cash consolidated,1
cash used,2
common stock offset,1
net cash provided,1
the year based,1
cash invested,1
foreign currency denominated forward,1
this report are,1
intend plan continue,1
track believe,1
generic pharmaceutical pricing including,1
regulatory environment including,1
pharmaceutical compounding declining,1
litigation including,2
facility managing,1
foreign expansion including,1
the period ended,2
schedule listed,1
all material respects,6
report dated,2
responsibility is,2
firm registered,2
evidence regarding,1
a liability has,2
the amount accrued,1
the company discloses,1
the opioid matters,1
a liability related,1
a legal contingency is,1
instance auditing,1
the significant judgment applied,1
litigation given,1
uncertainty associated,1
material misstatement related,1
footnote disclosures,1
the company has,8
segment have,2
the production processes,1
significant judgment is,1
the judgment used,1
management including,1
decree resulted,1
the company evaluated,1
value exceeded,1
rate ii,1
iii estimated,1
the final consent decree,1
group resulting,1
the methodology used,1
group including,1
rate selected,1
value authorized,1
capital retained,1
share vesting,4
cash provided,1
cash acquired,1
revenue arising,1
principle is,1
the entity expects,1
the adoption had,1
the company did not,1
the company elected,2
the company recognizes,1
the variable consideration is,1
consolidated balance sheets,1
the amended guidance is,1
the company does not,2
the net amount expected,1
a modified retrospective approach is,1
the guidance is,1
the company is currently,1
price recorded,1
insurance provided,1
the company records,5
policy prohibits,1
a quantitative impairment assessment,1
the company performs,2
fair value measurement,1
the company concluded,1
this evaluation is,1
an investment is,1
the entitys economic performance combined,1
an investment is not,1
expense is,2
equipment are,1
maintenance are,1
software developed,1
the project reach,1
revenue related,1
revenue is,1
the company is generally,1
revenue is primarily,2
consideration expected,1
a contract related,1
common stock sharebased,1
compensation paid,1
expense associated,2
compensation were,1
the reserve estimates,1
appropriate based,1
price was,2
price exceeded,2
the company is,1
the acquisition are,1
new longterm debt see,1
the acquisition strengthens,1
the acquisition are not,1
joint venture are,1
the noncontrolling interest was,1
control exceeded,1
the customer relationships,1
the consolidation are not,2
joint venture was,1
percentage acquired,1
joint venture exceeded,1
fair value measurements,1
the company is not,1
table summarizes,1
benefit are,1
staff issued,1
guidance regarding,1
the company completed,1
the fiscal quarter ended,14
information is,1
expiration dates,1
the company decreased,2
this decrease was,1
allowance had,1
the company had,1
position related,1
reserve recognized,1
the fiscal year see,1
this reserve was,1
the settlement was,1
unit was,1
the company entered,3
the company was,3
the facility is,1
vehicle utilized,1
an additional covenant requires,1
nonrecourse debt is,1
debt are,1
preferred stock have,1
common stock are,5
common stock included,1
common stock received,1
share is,2
plan covering,2
an internal committee comprised,1
the company sponsors,1
performance based,1
this unfunded plan provides,1
key management including,1
compensation exceeded,1
limit established,3
this plan provided,1
compensation exceeds,2
this plan provides,1
the amount deferred,1
compensation allocated,1
each full share credited,1
common stock have,3
liability relating,1
the option is,1
model expected,1
rate expected,1
expense relating,2
period ended,1
the company has not,1
uncertainty remains,1
the company is also,2
a motion permitting,1
an order creating,1
an order selecting,1
trial track,1
the company announced,1
the company were,1
announcement outlined,1
a global resolution given,1
a liability associated,1
a global resolution has not,1
significant uncertainty remains,1
the inherent uncertainty related,1
a motion proposing,1
court entered,1
an order accelerating,1
the court amended,1
information requesting,1
this matter was,1
pharmacy regulate,1
other industry participant,1
the government informed,1
action related,1
the case was,1
the relator has,1
the guilty plea resolves,1
the federal criminal investigation related,1
the reserve was,1
matter involving,1
the company reversed,1
class ie,1
the chief operating,1
function is,1
operating segments,1
reportable segment operating,1
total segment operating,2
capital expenditures,1
amortization includes,1
value based,1
market accounts,1
longterm debt see,1
longterm debt was,1
a noncustomer note receivable,1
that information required,2
management have,1
such term is,1
the period covered,5
this report changes,1
financial reporting is,2
reasonable assurance regarding,6
accounting principles,1
financial reporting includes,2
the company are,2
management assessed,1
this assessment management used,1
management has,1
financial reporting was,2
this report is,3
the company maintained,1
management is,1
financial reporting included,1
financial reporting based,1
audit included,1
weakness exists,1
internal control based,1
audit provides,1
a process designed,1
information appearing,5
schedule is,1
indenture dated,1
trustee incorporated,1
trustee related,12
buyer dated,1
originator incorporated,5
administrator incorporated,13
recipient incorporated,1
guarantor incorporated,3
ixbrl i,1
each marked exhibit is,1
duly authorized,1
this report has,1
the following description is,1
preferred stock are,1
incorporation authorizes,1
common stock entitled,1
specific information regarding,1
information regarding,1
special meeting make,1
the person became,1
combination is broadly,1
this prohibition is,1
the interested stockholder becoming,2
an interested stockholder is,1
the interested stockholder becomes,1
the interested stockholder owned,1
the stockholder becomes,1
combination is,1
incorporation provides,3
incorporation do not,1
the director derived,1
such person serves,1
the full extent authorized,1
any action asserting,3
a fiduciary duty owed,1
court located,2
this report does not,2
other financial information included,2
material information relating,2
prepared b designed,2
d disclosed,2
the date hereof,2
the information contained,2
statement required,1
this certification accompanies,1
the extent required,1
